(Q46707121)

English

Accumulation of azithromycin and roxithromycin in tracheal epithelial fetal cell lines expressing wild type or mutated cystic fibrosis transmembrane conductance regulator protein (CFTR).

scientific article published in August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16167517

Accumulation of azithromycin and roxithromycin in tracheal epithelial fetal cell lines expressing wild type or mutated cystic fibrosis transmembrane conductance regulator protein (CFTR). (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16167517

transmembrane protein

0 references

cystic fibrosis

0 references

0 references

author name string

Labro MT

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16167517

Babin-Chevaye C

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16167517

Mergey M

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16167517

publication date

1 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16167517

Journal of Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16167517

17

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16167517

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16167517

385-392

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16167517

Clinical implications of macrolide therapy in chronic sinopulmonary diseases

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

Tissue reparative effects of macrolide antibiotics in chronic inflammatory sinopulmonary diseases.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

Immunomodulation by macrolide antibiotics

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

The biochemistry of P-glycoprotein-mediated multidrug resistance

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

The P-glycoprotein multidrug transporter

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

Oncogene-mediated propagation of tracheal epithelial cells from two cystic fibrosis fetuses with different mutations. Characterization of CFT-1 and CFT-2 cells in culture.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophages

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

Immunomodulatory activity and effectiveness of macrolides in chronic airway disease

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

Macrolides in cystic fibrosis: is there a role?

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

Azithromycin for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

The use of macrolide antibiotics in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

Improved lung function and body mass index associated with long-term use of Macrolide antibiotics

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

Role of extracellular calcium in in vitro uptake and intraphagocytic location of macrolides

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

Expression of the cystic fibrosis transmembrane conductance regulator gene in cells of non-epithelial origin

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

Defective protein kinase C-mediated actions in cystic fibrosis neutrophils

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

New insights into the pathogenesis of cystic fibrosis: pivotal role of glutathione system dysfunction and implications for therapy

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

Sildenafil (Viagra) corrects DeltaF508-CFTR location in nasal epithelial cells from patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

Pharmacologic therapy for stop mutations: how much CFTR activity is enough?

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

Macrolide antibiotics: current and future uses

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

Azithromycin for improving pulmonary function in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

High Rate of Macrolide Resistance inStaphylococcus aureusStrains from Patients with Cystic Fibrosis Reveals High Proportions of Hypermutable Strains

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

Acute exacerbations due to Streptococcus pneumoniae in chronic lower respiratory tract infections during long-term macrolide therapy

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

Comparative pharmacodynamics of clarithromycin and azithromycin against respiratory pathogens.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.4.385

21 January 2018

Identifiers

10.1179/JOC.2005.17.4.385

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16167517

release_bnwigyp3xzbvhcis5u5xuy2g5m

1 reference

https://api.fatcat.wiki/v0/release/bnwigyp3xzbvhcis5u5xuy2g5m

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16167517

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46707121&oldid=1843773195"